Free Prostate Specific Antigen CLIA
- UID
- MFG/IVD/2020/000100_ade1809912ff1dd14e1cd98a27f2129d_9c8acb24413e83f1b9d90151b13a7f47
- Device class
- Class C
- Brand name
- ADA
- License holder
- Agappe Diagnostics Ltd
- Approving authority
- Central Drug Standard Control Organisation, South Zone
- Product information
- Differential diagnosis of prostate cancer and benign prostatic hyperplasia
Free Prostate Specific Antigen CLIA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000100_ade1809912ff1dd14e1cd98a27f2129d_9c8acb24413e83f1b9d90151b13a7f47. This device is marketed under the brand name ADA. The license holder is Agappe Diagnostics Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.